NorthCrest Asset Manangement’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,900
Closed -$754K 519
2023
Q2
$754K Hold
17,900
0.03% 297
2023
Q1
$638K Buy
17,900
+1,000
+6% +$36.3K 0.03% 316
2022
Q4
$620K Buy
16,900
+200
+1% +$7.91K 0.04% 244
2022
Q3
$787K Hold
16,700
0.04% 237
2022
Q2
$1.2M Hold
16,700
0.06% 190
2022
Q1
$1.35M Buy
16,700
+250
+2% +$21.1K 0.06% 168
2021
Q4
$1.69M Buy
+16,450
New +$1.58M 0.09% 165

Other funds holding SYNH

NorthCrest Asset Manangement's SYNH Position: Q3 2023 in Review

NorthCrest Asset Manangement sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 17,900 shares — an estimated $754K sold.

NorthCrest Asset Manangement first reported a position in SYNH in Q4 2021 and held it in 7 quarters. The position peaked at $1.69M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • NorthCrest Asset Manangement reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • NorthCrest Asset Manangement sold 17,900 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $754K.
  • NorthCrest Asset Manangement first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • NorthCrest Asset Manangement's Syneos Health, Inc. Class A Common Stock position peaked at $1.69M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2023, filed 13 Nov 2023.